Human IL-24/MDA-7 ELISA kitEK0482

• Aluminium pouches with a Microwell Plate coated with antibody to human IL-24 (8X12)
• 2 vials human IL-24 Standard lyophilized, 2000 pg/ml upon reconstitution
• 2 vials concentrated Biotin-Conjugate anti-human IL-24 antibody
• 2 vials Streptavidin-HRP solution
• 4 bottle Standard /sample Diluent
• 1 bottle Biotin-Conjugate antibody Diluent
• 1 bottle Streptavidin-HRP Diluent
• 1 bottle Wash Buffer Concentrate 20x (PBS with 1% Tween-20)
• 1 vial Substrate Solution
• 1 vial Stop Solution
• 4 pieces Adhesive Films
• package insert

Interleukin 24(IL-24),also known as mda7 (melanoma differentiation associated gene7),is a member of the IL10 family of helical cytokines. The IL-24 gene encodes a precursor protein of 207 amino acids (aa) that contains a 48 aa signal sequence and an 18 kDa, 158 aa mature segment. There are three potential Nlinked glycosylation sites, at least one of which is used. When secreted, IL-24 is a 3540 kDa phosphorylated glycoprotein that apparently can exist as either a monomer or dimer. It is suggested that glycosylation is essential for activity. Mature human IL-24 shares 69% aa sequence identity with mouse and rat IL-24. Human IL-24 is also active in rodent systems. Cells known to express IL-24 include B cells, CD4+ T cells, NK cells, lymph node dendritic cells, monocytes, melanocytes, and melanoma cells. Functionally, IL-24 has diverse activities. At low concentrations on monocytes, it induces type I proinflammatory cytokines such as IFN-γ, IL-1β,IL-12, and TNF-α. At high concentrations, it is a strong inducer of apoptosis in tumor cells, but not normal cells. IL-24 also has antiangiogenic properties. It directly binds IL-24 receptors on endothelial cells, activating STAT3 and blocking their differentiation. IL-24 binds and signals through two heterodimeric receptor complexes. One complex is the combination of IL-20Rα and IL-20Rβ, which is shared with IL-19 and IL-20. The second complex is a combination of IL-22R and IL-20Rβ, which is shared with IL-20.

Jiang, H. et al. (1995) Oncogene 11:2477.

Jiang, H. et al. (1996) Proc. Natl. Acad. Sci. USA 93:9160.

Wang, M. et al. (2002) J. Biol Chem. 227:7341.

Chada, S. et al. (2004) Int. Immunopharmacol. 4:649.

Pestka, S. et al. (2004) Annu. Rev. Immunol. 22:929.

Chen, J. et al. (2003) Molec. Ther. 8:220.